表紙：シラミ治療薬の市場規模・シェア・成長分析 (製品種類別、投与経路別、症状別、剤形別、流通チャネル別、地域別)：産業予測 (2025～2032年)

市場調査レポート

商品コード

1758578

シラミ治療薬の市場規模・シェア・成長分析 (製品種類別、投与経路別、症状別、剤形別、流通チャネル別、地域別)：産業予測 (2025～2032年)

Lice Treatment Market Size, Share, and Growth Analysis, By Product Type, By Type, By Route of Administration, By Condition, By Dosage Form, By Distribution Channel, By Region - Industry Forecast 2025-2032

出版日: 2025年06月19日
発行: SkyQuest
ページ情報: 英文 193 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 766,910円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 897,140円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,027,370円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.70円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界のシラミ治療薬の市場規模は、2023年に22億米ドルと評価され、2024年の23億5,000万米ドルから2032年には40億1,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは6.9%で成長する見通しです。

シラミ治療薬市場は、シラミの蔓延率の上昇、市販の治療薬へのアクセスの容易さ、治療製剤の革新的進歩など、いくつかの重要な要因により繁栄が見込まれています。政府の健康への取り組みや、自然で無害な製品への嗜好の高まりが、世界市場の需要をさらに高めています。学校のような過密環境でのシラミの発生が増加していることに加え、オンライン小売プラットフォームの利便性が製品の入手しやすさを高め、企業にとっては市場拡大の機会となっています。しかし、化学治療に対する抵抗性の高まり、副作用の可能性、低所得地域でのアクセス制限、社会的烙印といった課題は、2032年までの市場浸透を妨げる可能性があります。これらの洞察を総合すると、シラミ治療薬分野における成長の可能性と限界の両方が浮き彫りになります。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情勢

上位5社の比較
主要企業の市場ポジショニング (2024年)
主要企業が採用した戦略
市場の近年の動向
主要企業の市場シェア (2024年)
主要企業のプロファイル
- 企業概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
- 収益の前年比比較 (2022～2024年)

主要企業プロファイル

Johnson & Johnson Services, Inc.（USA）
Reckitt Benckiser Group plc（UK）
Perrigo Company plc（Ireland）
Prestige Consumer Healthcare Inc.（USA）
Sanofi S.A.（France）
GlaxoSmithKline（GSK）plc（UK）
Teva Pharmaceutical Industries Ltd.（Israel）
Pfizer Inc.（USA）
F. Hoffmann-La Roche Ltd.（Switzerland）
Sun Pharmaceutical Industries Ltd.（India）
ParaPRO LLC.（USA）
Alliance Pharma PLC（UK）
Arbor Pharmaceuticals, LLC.（USA）
Oystershell Consumer Health（Belgium）
Taro Pharmaceuticals（Canada）
ICB PHARMA（Poland）
Lice Clinics of America（USA）

結論と提言

Product Code: SQMIG35D2312

Global Lice Treatment Market size was valued at USD 2.2 billion in 2023 and is poised to grow from USD 2.35 billion in 2024 to USD 4.01 billion by 2032, growing at a CAGR of 6.9% during the forecast period (2025-2032).

The lice treatment market is expected to flourish due to several key factors, including the rising prevalence of lice infestations, easy access to over-the-counter treatments, and innovative advancements in treatment formulations. Government health initiatives and a growing preference for natural, non-toxic products further bolster global market demand. Increased occurrences of lice in overcrowded environments, like schools, alongside the convenience of online retail platforms, enhance product accessibility and market expansion opportunities for companies. However, challenges such as rising resistance to chemical treatments, potential side effects, limited access in low-income areas, and social stigma may hinder market penetration through 2032. Collectively, these insights highlight both the growth potential and limitations within the lice treatment sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Lice Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Lice Treatment Market Segments Analysis

Global Lice Treatment Market is segmented by Product Type, Type, Route of Administration, Condition, Dosage Form, Distribution Channel and region. Based on Product Type, the market is segmented into OTC products and Prescription medications. Based on Type, the market is segmented into Branded and Generic. Based on Route of Administration, the market is segmented into Oral and Topical. Based on Condition, the market is segmented into Pediculosis capitis, Pediculosis corporis and Pediculosis pubis. Based on Dosage Form, the market is segmented into Tablets, Shampoos, Lotions, Cream and Other dosage forms. Based on Distribution Channel, the market is segmented into Hospital pharmacies, Retail pharmacies and Other distribution channels. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Lice Treatment Market

The Global Lice Treatment market is being propelled by innovations in treatment formulations that significantly enhance both effectiveness and user safety. Modern products, particularly those that are non-pesticide and silicone-based, effectively immobilize lice without relying on neurotoxins, thereby minimizing the risk of resistance. These advanced treatments are often odorless, cause less irritation, and require shorter application times, which ultimately improves the user experience. As a result, consumers are more likely to trust and feel satisfied with these options, leading to increased repeat purchases and positively impacting the market's growth trajectory in the coming years.

Restraints in the Global Lice Treatment Market

The global lice treatment market faces significant restraints due to the increasing resistance of lice to commonly used treatments. Chemical agents like permethrin and pyrethrin, which were once effective, have lost their potency due to overuse, resulting in treatment failures that frustrate consumers and lead to a decline in brand trust and repeat purchases. The emergence of "super lice," which are resistant to multiple chemical formulations, further complicates treatment options and underscores the need for alternative solutions. As a result, the growing demand for non-chemical treatments has contributed to a slowdown in the overall growth of the lice treatment industry.

Market Trends of the Global Lice Treatment Market

The Global Lice Treatment market is witnessing a significant trend towards preventive care, shifting from traditional reactive treatments to proactive measures. Parents and educational institutions are increasingly prioritizing strategies aimed at preventing lice infestations, resulting in heightened demand for products such as lice-repelling shampoos, sprays, and combs, especially those enriched with essential oils like rosemary and eucalyptus. This focus on prevention is not only broadening the product offering but also encouraging consumers to adopt consistent, long-term usage patterns. As awareness around lice prevention grows, the global market is expected to expand, catering to a more health-conscious demographic seeking effective solutions to combat lice infestations.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Lice Treatment Market Size by Product Type & CAGR (2025-2032)

Market Overview
OTC products
- Permethrin
- Pyrethrin
- Other OTC products
Prescription medications
- Ivermectin
- Spinosad
- Malathion
- Other prescription medications

Global Lice Treatment Market Size by Type & CAGR (2025-2032)

Market Overview
Branded
Generic

Global Lice Treatment Market Size by Route of Administration & CAGR (2025-2032)

Market Overview
Oral
Topical

Global Lice Treatment Market Size by Condition & CAGR (2025-2032)

Market Overview
Pediculosis capitis
Pediculosis corporis
Pediculosis pubis

Global Lice Treatment Market Size by Dosage Form & CAGR (2025-2032)

Market Overview
Tablets
Shampoos
Lotions
Cream
Other dosage forms

Global Lice Treatment Market Size by Distribution Channel & CAGR (2025-2032)

Market Overview
Hospital pharmacies
Retail pharmacies
Other distribution channels

Global Lice Treatment Market Size & CAGR (2025-2032)

North America (Product Type, Type, Route of Administration, Condition, Dosage Form, Distribution Channel)
- US
- Canada
Europe (Product Type, Type, Route of Administration, Condition, Dosage Form, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Type, Route of Administration, Condition, Dosage Form, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Type, Route of Administration, Condition, Dosage Form, Distribution Channel)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Type, Route of Administration, Condition, Dosage Form, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Johnson & Johnson Services, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Reckitt Benckiser Group plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Perrigo Company plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Prestige Consumer Healthcare Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline (GSK) plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sun Pharmaceutical Industries Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ParaPRO LLC. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alliance Pharma PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arbor Pharmaceuticals, LLC. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oystershell Consumer Health (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Taro Pharmaceuticals (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ICB PHARMA (Poland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lice Clinics of America (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

シラミ治療薬の市場規模・シェア・成長分析 (製品種類別、投与経路別、症状別、剤形別、流通チャネル別、地域別)：産業予測 (2025～2032年)

Lice Treatment Market Size, Share, and Growth Analysis, By Product Type, By Type, By Route of Administration, By Condition, By Dosage Form, By Distribution Channel, By Region - Industry Forecast 2025-2032

目次

イントロダクション

分析手法

エグゼクティブサマリー

市場力学と見通し

市場の主な考察

世界のシラミ治療薬の市場規模・CAGR：製品種類別 (2025～2032年)

世界のシラミ治療薬の市場規模・CAGR：種類別 (2025～2032年)

世界のシラミ治療薬の市場規模・CAGR：投与経路別 (2025～2032年)

世界のシラミ治療薬の市場規模・CAGR：症状別 (2025～2032年)

世界のシラミ治療薬の市場規模・CAGR：剤形別 (2025～2032年)

世界のシラミ治療薬の市場規模・CAGR：流通チャネル別 (2025～2032年)

世界のシラミ治療薬の市場規模・CAGR (2025～2032年)